HMGCR and Huntington disease: In this Mendelian randomization analysis of 9064 HD patients of European descent, the plasma LDL-C levels and the reduction in plasma LDL cholesterol levels by the inhibition of HMG-CoA reductase (i.e., statins) were not associated with the age of HD onset.